Risk assessment and management of atrial fibrillation patients with left atrial thrombus

Kazuo Miyazawa; Professor Gregory Lip

doi:10.1111/pace.13556

Discussion(0)

No comments yet. Be the first to comment.

Related publications

Article2020

Short-Term Apixaban for Documented Left Atrial Appendage Thrombus in High-Risk Atrial Fibrillation Patients Undergoing Left Atrial Appendage Occlusion

Wern Yew Ding, Professor Gregory Lip, Timothy Fairbairn, Sukumaran Binukrishnan, Afshin Khalatbari, Periaswamy Velavan, Dhiraj Gupta

Article2022

Clinical Features Associated with ‘Normal Range’ Fibrin D-Dimer Levels in Atrial Fibrillation Patients with Left Atrial Thrombus

Ying Bai, Si-Qing Luo, Sitong Liu, Ling Gong, Peng Zhong, Zhenzhou Wang, Professor Gregory Lip, Yi-Xi Zou, Weihua Guo

Article2022

Management of Patients at Risk for and With Left Ventricular Thrombus: A Scientific Statement From the American Heart Association

Glenn N. Levine, John W. McEvoy, James C. Fang, Chinwe Ibeh, Cian P. McCarthy, Arunima Misra, Zubair Shah, Chetan Shenoy, Sarah A. Spinler, Srikanth Vallurupalli, Professor Gregory Lip

Article2018

Integrated Care Management of Patients With Atrial Fibrillation and Risk of Cardiovascular Events

Daniele Pastori, Pasquale Pignatelli, Danilo Menichelli, Francesco Violi, Professor Gregory Lip

Article2007

Outcome of atrial resynchronisation therapy in patients unsuitable for left atrial ablation for the management of drug resistant atrial fibrillation

Rajiv Sankaranarayanan, Martin James